Microbot Medical (MBOT) Net Cash Flow (2010 - 2026)

Microbot Medical has reported Net Cash Flow for 17 years, with the latest figure at -$56000.0 in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 154.9% year-over-year to -$56000.0; the trailing twelve-month figure through Mar 2026 stood at $652000.0 (down 68.27% YoY), and the FY2025 full-year result was $810000.0, up 25.39% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$56000.0, up from -$2.8 million in the prior quarter.
• The five-year high for Net Cash Flow was $2.6 million in Q4 2024, with the low at -$6.2 million in Q4 2022.
• Historically, Net Cash Flow has averaged -$1.2 million across 5 years, with a median of -$1.3 million in 2024.
• Annual changes were most pronounced in 2022 — Net Cash Flow sank 9241.18% — and 2025, when it soared 232.07%.
• Microbot Medical's Net Cash Flow stood at -$6.2 million in 2022, then jumped by 118.28% to $1.1 million in 2023, then surged by 132.04% to $2.6 million in 2024, then tumbled by 205.65% to -$2.8 million in 2025, then soared by 97.99% to -$56000.0 in 2026.
• The last three Net Cash Flow figures came in at -$56000.0 (Q1 2026), -$2.8 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.